SINGAPORE INSTITUTE OF ADVANCED MEDICINE HOLDINGS LTD.

Singapore Institute of Advanced Medicine Holdings Ltd.

9G2

SGXE79544776

Healthcare Facilities & Services

Delayed Singapore S.E. Other stock markets 06:42:11 13/06/2025 am IST			5-day change	1st Jan Change
0.0290 ^SGD	0.00%		-3.33%	-47.27%

28/03	Subsidiary Increases Share Capital in SIAM	MT
27/03	Proton Therapy Pte Ltd. announced that it has received SGD 153.175528 million in funding from Singapore Institute of Advanced Medicine Holdings Ltd. and other investors	CI

Singapore Institute of Advanced Medicine Holdings Raises S$G26.2 million on Singapore Stock Exchange Debut

Published on 16/02/2024 at 12:32, updated on 16/02/2024 at 12:33

This article is reserved for members

Unlock the article: REGISTER NOW!

100% Free Registration

Already a customer? Log In

Latest news about Singapore Institute of Advanced Medicine Holdings Ltd.

Subsidiary Increases Share Capital in SIAM	28/03	MT
Proton Therapy Pte Ltd. announced that it has received SGD 153.175528 million in funding from Singapore Institute of Advanced Medicine Holdings Ltd. and other investors	27/03	CI
Singapore Institute Of Advanced Medicine Enters Loan Agreement Of Up To S$6 Million	27/02	RE
Singapore Institute of Advanced Medicine Extends Maturity for SG$5 Million Loan to December	27/02	MT
Singapore Institute of Advanced Medicine Holdings Ltd. Provides Update in Relation to Loan Agreement with Caterine Limited	26/02	CI
Singapore Institute of Advanced Medicine Trims Loss in Fiscal H1	18/02	MT
37,267,094 Shares of Singapore Institute of Advanced Medicine Holdings Ltd. are subject to a Lock-Up Agreement Ending on 16-FEB-2025.	16/02	CI
Singapore Institute Of Advanced Medicine Updates HY Results	14/02	RE
Singapore Institute of Advanced Medicine Holdings Ltd. Reports Earnings Results for the Half Year Ended December 31, 2024	14/02	CI
Singapore Institute of Advanced Medicine Issues Nearly 4 Million Shares	12/02	MT
Singapore Institute of Advanced Medicine Secures SG$5 Million Loan	23/12	MT
Singapore Institute of Advanced Medicine Holdings Ltd. Entry into Loan Agreement with Caterine Limited	20/12	CI
Singapore Shares Close Week Higher as US Trade Fears Grow; XHM Surges 53%	13/12	MT
Singapore Institute of Advanced Medicine to Form Strategic Review Committee; Shares Plunge 27%	13/12	MT
Singapore Institute of Advanced Medicine Holdings Ltd. Establishes Strategic Review Committee	12/12	CI
Singapore Shares Rebound on US Interest Rate Cut Hopes; Singapore Institute of Advanced Medicine Surges 40%	12/12	MT
PwC Flags Going Concern For Singapore Institute of Advanced Medicine; Shares Surge 40%	12/12	MT
Singapore Institute of Advanced Medicine Extends Partnership Talks with EnGeneIC	04/12	MT
Singapore Shares Tumble Despite Improved Business Outlook; Aztech Global Plunges 27%	30/24/30	MT
Singapore Institute of Advanced Medicine's Loss After Tax Widens in H1; Shares Plunge 15%	30/24/30	MT
Singapore Institute of Advanced Medicine Holdings Ltd. Reports Earnings Results for the Full Year Ended June 30, 2024	29/24/29	CI
Singapore Institute of Advanced Medicine Gets 60-Day Extensions for AGM, Annual Result Filing	11/24/11	MT
Singapore Institute of Advance Medicine Secured More Time to Publish Fiscal 2024 Results	19/24/19	MT
Singapore Institute of Advanced Medicine Holdings Ltd Announces Variation to Binding Term Sheet with Engeneic Pty Limited	05/24/05	CI
Certain Shares of Singapore Institute of Advanced Medicine Holdings Ltd. are subject to a Lock-Up Agreement Ending on 16-AUG-2024.	16/24/16	CI

Chart Singapore Institute of Advanced Medicine Holdings Ltd.

Duration

Period

Chart Singapore Institute of Advanced Medicine Holdings Ltd.

9G2: Dynamic Chart

Singapore Institute of Advanced Medicine Holdings Ltd is an investment holding company. The Company is a healthcare service provider using advanced technology for early and accurate diagnosis and offering treatments. Its services cater to a range of diseases and health conditions including, but not limited to, cancer, neurodegenerative and cardiovascular disease detection and treatment. The Companyâs segments include Medical Diagnostics and Treatments, and Radiation Therapy and Medical Oncology Services. Medical diagnostics and treatments segment cover cancer-related diagnostics and theragnostic treatments; general diagnostics and health screening; and aesthetic services. Radiation Therapy and Medical Oncology Services segment includes cover proton beam therapy, photon radiation therapy, and medical oncology. The Company's subsidiaries include Advanced Medicine Imaging Pte. Ltd., Advanced Medicine Oncology Pte. Ltd., Advanced Medicine Radiopharmaceutical Pte. Ltd., among others.

Employees

Sector

Healthcare Facilities & Services

More about the company